Painkillers: The ‘popular’ painkiller that may 'triple' the risk of stroke – BMJ study

The team also looked at COX-2 inhibitors, a new generation anti-inflammatory drug.

To evaluate the effects of both drugs, researchers analysed randomised control trials comparing NSAID, with other forms of the anti-inflammatory pill or placebo.

A total of thirty-one trials were completed, with 116,429 patients involved.

The results revealed that rofecoxib and lumiracoxib were associated with twice the risk of heart attack when compared with placebo.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more